GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 1,031.00
+9.00 (0.88%)
Mar 20, 2026, 12:20 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 87.07 billion as of March 19, 2026. Its market cap has decreased by -47.05% in one year.
Market Cap
87.07B
Enterprise Value
114.75B
Revenue
30.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,031.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 87.07B, an increase of 2,461.03%. That is a compound annual growth rate of 11.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 87.07B | -47.83% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 218.98B |
| Vaxcell-Bio Therapeutics | 188.38B |
| MedPacto | 183.71B |
| Macrogen | 178.34B |
| ENCell | 170.06B |
| iNtRON Biotechnology | 139.48B |
| CG Invites | 108.04B |
| Amicogen | 97.65B |